More Women Than Men Experience Nonphysical Violence in Health Care Workforce
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, July 12, 2024 -- Women in the health care workforce are more likely to experience verbal abuse, sexual harassment, and bullying, while men are more likely to experience physical violence, according to a study published online July 2 in PLOS Global Public Health.
Sioban Nelson, R.N., Ph.D., from the University of Toronto, and colleagues conducted a scoping review and report on the prevalence and risk factors of gender-based workplace violence (GB-WPV) in health care settings. Data from 226 studies were included in the analysis.
The researchers found that more women than men experienced nonphysical violence, including verbal abuse, sexual harassment, and bullying, across the studies. Compared with women, men experienced more physical violence. Characteristics that were sensitive to gender included younger age, less experience, shifting duties, specific clinical settings, lower professional status, organizational hierarchy, and minority status, which reflected the structural disadvantages of women in the workplace.
"The repercussions of GB-WPV resonate throughout the health care system, resulting in substantial provider attrition, compromised patient care, and an overburdened health care infrastructure struggling to meet the needs of society," the authors write. "We acknowledge that looking at a single analytical category, such as gender, negates the complex ways in which other social categories influence experiences of WPV."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-13 07:15
Read more
- Metformin Use Tied to Lower Rate of Asthma Attacks
- Florida Fails to Pass Amendment Legalizing Recreational Weed
- A Visit to the ER Can Often Precede a Cancer Diagnosis
- Cognitive Decline Slowed With Cognitive Remediation in At-Risk Adults
- Psychologists' Group Issues First Guidance to Parents on Teen Online Video Use
- Certain Pesticides Tied to Increased Prostate Cancer Incidence, Mortality
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions